McGrath J A, Darling T, Gatalica B, Pohla-Gubo G, Hintner H, Christiano A M, Yancey K, Uitto J
Department of Dermatology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
J Invest Dermatol. 1996 Apr;106(4):771-4. doi: 10.1111/1523-1747.ep12345821.
The 180-kDa bullous pemphigoid antigen (BPAG2) is a candidate gene/protein for mutations in some forms of junctional epidermolysis bullosa. In this study, we searched for mutations in BPAG2 in a large Austrian pedigree with generalized atrophic benign epidermolysis bullosa, a distinct nonlethal form of junctional epidermolysis bullosa, using polymerase chain reaction amplification of genomic DNA, heteroduplex analysis of the polymerase chain reaction products, and direct nucleotide sequencing. We identified a homozygous 2-bp deletion within the coding region of BPAG2 in the affected individuals. This mutation results in a frameshift and downstream stop codons on both alleles, predicting an absence of functional protein. These findings illustrate the molecular basis of the skin fragility in this family and attest to the importance of the 180-kDa bullous pemphigoid antigen in the attachment of the epidermis to the underlying dermoepidermal basement membrane.
180 kDa大疱性类天疱疮抗原(BPAG2)是某些交界型大疱性表皮松解症形式中发生突变的候选基因/蛋白。在本研究中,我们使用基因组DNA的聚合酶链反应扩增、聚合酶链反应产物的异源双链分析和直接核苷酸测序,在一个患有全身性萎缩性良性大疱性表皮松解症(一种独特的非致死性交界型大疱性表皮松解症)的大型奥地利家系中寻找BPAG2的突变。我们在受影响个体的BPAG2编码区内鉴定出一个纯合的2碱基缺失。该突变导致两个等位基因均发生移码和下游终止密码子,预测无功能性蛋白。这些发现阐明了该家族皮肤脆弱的分子基础,并证明了180 kDa大疱性类天疱疮抗原在表皮与下方真皮表皮基底膜附着中的重要性。